Skip to content

Changes in Heart Rate Variability And Heart Rate/Activity Slope After Hospitalization for Acute Exacerbations of COPD

Changes in Heart Rate Variability And Heart Rate/Activity Slope Measures After Hospitalization for Acute Exacerbations of COPD: An Observational Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05290831
Acronym
CHARM COPD
Enrollment
45
Registered
2022-03-22
Start date
2022-04-10
Completion date
2024-04-01
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Brief summary

The purpose of this study is to observe the variation in time between heart beats and how heart rate changes during activity evolve after hospitalization for an exacerbation of COPD.

Detailed description

The investigators will place a monitoring patch that continuously records electrocardiogram and activity. Participants will switch this patch every 7 days for a total of 28 days. From these data the investigators will observe how heart rate variability and heart rate responses to exercise evolve after hospitalization for an exacerbation of COPD.

Interventions

DEVICEVitalPatch

The VitalPatch continuously monitors skin temperature, activity, and electrocardiography.

Sponsors

Minneapolis Veterans Affairs Medical Center
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Signed informed consent 2. At least moderate COPD by Global Initiative for Chronic Obstructive Lung Disease spirometry criteria (FEV1/FVC \< 0.7 and FEV1 \< 80% predicted) 3. 10 pack year smoking history 4. Hospitalized with one or more of: 1. increased dyspnea 2. increased sputum 3. change in sputum character 5. Treated with corticosteroids and/or antibiotics for respiratory indications 6. Age \> 40 years old

Exclusion criteria

1. Discharging home on hospice 2. Inability to follow trial protocols 3. Pacemaker 4. Allergy to a component of the adhesive patches 5. Breastfeeding 6. Permanent/continuous atrial fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Model fit from repeated measures mixed model of heart rate/activity slope28 daysThe investigators will average heart rate and activity (from accelerometer output) over 30-second periods. The highest 30-second average from each 5 minute period will be used to create the heart rate/activity slope for each 24-hour period while the device is worn. They will then model the change in heart rate/activity slope using a linear-mixed effect model with a random intercept and slope for each individual.
Heart rate variability slopes (time and frequency-domain)28 daysThe investigators will use Kubios software to calculate heart rate variability (time and frequency domain measurements) for each 24-hour period that the patch is worn. They will use repeated mixed measures models with random intercept and slope to model the change in heart rate variability after discharge.

Secondary

MeasureTime frameDescription
Comparison of heart rate/activity slope in participants readmitted vs not-readmitted28 daysThe investigators will compare heart rate/activity slope in participants who are readmitted to the hospital within 28 days to those who are not readmitted to the hospital within 28 days using a linear mix-effect model with random intercept and slope.
Comparison of heart rate variability slope in participants readmitted vs not-readmitted28 daysThe investigators will compare heart rate variability slopes (time and frequency domain) in participants who are readmitted to the hospital within 28 days to those who are not readmitted to the hospital within 28 days using a linear mix-effect model with random intercept and slope.
Acceptability to participants28 daysWe will query participants if the monitoring patch would be acceptable if it were shown to improve their care for COPD.

Contacts

Primary ContactDavid MacDonald, MD, MS
david.macdonald2@va.gov612-725-2000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026